US Patent Issued to DENALI THERAPEUTICS on Sept. 29 for "Compounds, compositions, and methods" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,232, issued on Sept. 29, was assigned to DENALI THERAPEUTICS INC. (South San Francisco, Calif.).

"Compounds, compositions, and methods" was invented by Javier de Vicente Fidalgo (Foster City, Calif.), Anthony A. Estrada (San Mateo, Calif.), Jianwen A. Feng (San Mateo, Calif.), Joseph P. Lyssikatos (Piedmont, Calif.) and Zachary K. Sweeney (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof."

The patent wa...